Company page

Read-gene Sa

Read-gene SA is a public company listed on the Polish market under the ticker RDG, with a market capitalization of approximately 16.5 million. The company focuses on advancements in genetic research and technology. Its operations aim to contribute to the growing field of genomics and personalized medicine.

profileRDG:NEWCONNECTAI content: aiUpdated June 24, 2026/company/read-gene-sa/c-0ut0ryuy
Read-gene Sa logo
Ticker
RDG:NEWCONNECT
Asset type
Stock
Market cap
$16.5M
Sector
Health Technology
Industry
Biotechnology
Exchange
NEWCONNECT
Currency
PLN